Invibio

Implant-grade PEEK polymers and biomaterial solutions for medical device manufacturers

Cleveleys, United KingdomFounded 2000invibio.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-30

About Invibio

Invibio supplies PEEK-OPTIMA polymers and other biomaterial solutions, provides technical research and regulatory support, and manufactures components for long-term implantable medical devices.

Its customers are medical device manufacturers developing products for spine, trauma, orthopaedic, dental and other medical applications. Invibio is part of the Victrex plc group of companies and is headquartered in Cleveleys, United Kingdom; it offers career opportunities across the globe.

Product: Implant-grade PEEK polymers, biomaterial solutions, technical support and manufactured components for medical devices.

Jobs at Invibio

No open positions listed right now.

More biotech & pharma companies

  • Invox Pharma

    Develops respiratory medicines and soft-mist inhaler products for patients and pharmaceutical partners
    London, United KingdomBiotech & pharmaFounded 2021
    New on Evolc
  • Iota Sciences

    Automated single-cell isolation and cloning systems and cell-line engineering services for life-sciences researchers
    Yarnton, United KingdomBiotech & pharmaFounded 2016
    New on Evolc
  • Ipsen

    Develops and sells medicines in oncology, rare diseases and neuroscience for patients and healthcare professionals
    London, United KingdomBiotech & pharmaFounded 2008193 open jobs
    New on Evolc
  • Isomorphic Labs

    AI-driven drug discovery platform building predictive and generative models for pharmaceutical research and development
    London, United KingdomBiotech & pharmaFounded 202143 open jobs
    Remote-friendly
  • Istesso

    Develops oral mitochondrial Complex I modulator medicines to restore tissue repair; lead candidate leramistat is in Phase 2
    London, United KingdomBiotech & pharmaFounded 2017
    New on Evolc
  • Itf Pharma

    Rare-disease pharmaceutical company developing treatments for Duchenne muscular dystrophy in the UK and Ireland
    London, United KingdomBiotech & pharmaFounded 2023
    Young companyNew on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • ASP.NET
  • Azure
  • Google Tag Manager
  • Next.js
  • React